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ABSTRACT
Electronic health records are increasingly used for research. The deﬁnition of cases or endpoints often relies on the use of coded diagnostic
data,usingapre-selected group ofcodes. Validationofthese cases,as‘true’ cases ofthe disease, is crucial. There are, however,ambiguitiesin
what is meant by validation in the context of electronic records. Validation usually implies comparison of a deﬁnition against a gold standard
of diagnosis and the ability to identify false negatives (‘true’ cases which were not detected) as well as false positives (detected cases which
did not have the condition). We argue that two separate concepts of validation are often conﬂated in existing studies. Firstly, whether the GP
thought the patient was suffering from a particular condition (which we term conﬁrmation or internal validation) and secondly, whether the
patient really had the condition (external validation). Few studies have the ability to detect false negatives who have not received a diagnostic
code. Natural language processing is likely to open up the use offree text within the electronic record which will facilitate both thevalidation
of the coded diagnosis and searching for false negatives. Copyright # 2011 John Wiley & Sons, Ltd.
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Electronic health records (EHRs) offer great potential
for research, enabling the rapid identiﬁcation of
patients for inclusion in intervention or observational
studies. As their use becomes more widespread, it is
important to understand the structure of the data that
constitute these records. Primary care records in the
UK have been computerised for several decades and in
the UK electronic records are almost universal in GP
practices. Several anonymised databases of primary
care records exist which have been used extensively in
research studies,
1 including the General Practice
Research Database (GPRD – www.gprd.com). EHRs
also exist in secondary care settings and the data are
then collated for various administrative or research
purposes such as national disease registers or Hospital
Episode Statistics (HES).
EHR systems use a combination of structured coded
data and unstructured free text ﬁelds. The balance
between these two components varies across different
record systems with some EHRs consisting entirely of
coded data. In some systems, such as HES in the UK,
professional coders enter the codes based on the
clinical records but in others, such as primary care, the
code is entered by the clinician as part of routine care.
In primary care systems, where text and codes are
entered during clinical care, the factors determining
whether information is entered as text or code are
poorly understood. Research studies ﬁnd it difﬁcult to
accessanduselargeamountsoffreetext–duetoissues
of conﬁdentiality, costs of anonymisation and the need
to structure/code the information contained. Hence
nearly all studies that use the GPRD (or most other
electronic record systems) rely on coded diagnoses to
identify cases, and related validation studies attempt to
show whether cases with diagnostic codes do indeed
have that condition. ‘Validation’ is often reported as a
quality marker both of the results of the research and of
the records used. Two recent papers have reviewed the
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2,3 They have
provided an excellent summary of the types of studies
undertaken and shown that most (90%) coded
diagnoses, from a range of conditions, are ‘validated’.
There are, however, currently systematic ambiguities
in how the term validation is currently used in this ﬁeld
compared to other diagnostic contexts.
In this paper, we address three issues concerning the
use of EHRs in research. First, we discuss what
validation means in the context of EHR research and
suggest that there are two distinct types of validation –
internal and external. We then go on to explore the
widespread failure in EHR research to address the
question of false negatives, that is cases of the disease
whohavenotreceived adiagnostic code.We arguethat
these should be identiﬁed as far as possible in any
validation study. Finally, we discuss the relation of
code-choice to validation, arguing that sensitivity
analyses to investigate the impact of code choice on
study results should become standard practice. In
conclusion, we suggest that computational techniques,
such as natural language processing (NLP) which
access free text, have the potential to tackle these
challenges.
Conﬁrmation or validation?
There is ambiguity about what is meant by validation.
Two related but distinct concepts are being conﬂated in
the existing validation studies. The accuracy of a
diagnostic codewithin an electronic record depends on
two steps: whether the code accurately reﬂects the
practitioner’s opinion and whether that diagnosis was
correct.
(1) Did the GP think that the patient had this con-
dition? – conﬁrmation or internal validation.
Sometimes a tentative diagnosis is coded then
subsequently excluded, but the code remains on
the record. Occasionally, a code may be entered in
error and not corrected. Without further infor-
mation it is unclear whether the code actually
reﬂects the overall content of the records. The
majority of existing validation studies address this
question using additional information from the
practice, either using the additional data in the
EHR in the form of a diagnostic algorithm or
through questionnaires or record request to the
GP. We would suggest that this process is
correctly considered as conﬁrmation of the code
or internal validation rather than any external
validation of the diagnosis. It is testing whether
the code represents the GP record accurately. If a
primary care-based diagnosis only is required for
the research study, then such conﬁrmation/internal
validationfrompractice recordsissufﬁcient.Inthe
past this has involved obtaining paper records but
as Herrett et al.
2 discuss this leads to a potential
bias as only a (possibly non-representative) pro-
portion of practices take part in such additional
studies. We would question the need for such
contact. Paper records are becoming less common
in primary care and in many cases the electronic
record, including free text, is considered the com-
plete legal record.
(2) Was the GP correct? – external validation. This is
a more classic validation of the diagnosis against
some gold standard, the form of which will vary
according to condition. For some, such as myo-
cardial infarction, this may involve formal diag-
nostic criteria or need linkage to other data such as
HES or disease registers such as the cancer regis-
tries or Myocardial Ischaemia National Audit Pro-
ject (MINAP http://www.rcplondon.ac.uk/clinical-
standards/organisation/partnership/Pages/
MINAP-.aspx). More often a hospital diagnosis
reporting histology or the opinion of a specialist
will sufﬁce. Since the recording of information
received from specialists or secondary care in GP
databases is not standardised and may often not be
coded but entered into free text, methods which
allow text to be searched will facilitate such vali-
dation. We term this external validation as it uses
information which has been directly or indirectly
sourced from outside the GP practice.
The need for internal or external validation will
therefore depend on the clinical condition, and the
nature of the research question. For example, studies
examining the management of conditions wholly con-
tained within primary care can use conﬁrmation or
internal validation, since the focus is what the GP did
once she/he had made the diagnosis. However, inci-
dence studies for complex conditions managed in
collaboration with secondarycare may require external
validation.
Finding false negatives
A well-recognised weakness of existing validation/
conﬁrmation studies is that with a few exceptions
4,5
they do not consider the cases which have been missed
by relying on coded data, i.e. patients with the
condition who do not have a diagnostic code. Any
missed cases will consist both of cases where the GP
did not make the diagnosis and diagnosed but uncoded
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difﬁcult as it would require complete coding of
symptoms and signs. Relevant diagnostic tests may
not have been performed if the diagnosis was not
considered.
We will, therefore, focus on the more tractable issue
of diagnosed but uncoded cases. Here the GP has made
the diagnosis but did not code it. The balance between
the coding of diagnosis versus symptoms or signs is
poorly understood and is likely to be related to
decision-making and certainty in diagnosis.
6 There is
evidence that this balance may change over time, for
example that depressive illness has been more likely to
be coded as symptoms than as a diagnosis in recent
years.
7Potentiallystigmatisingdiagnosesmaybemore
likely to be put in text only so that it does not occur in
summary records. It has been estimated that only 50%
of HIV positive patients have their diagnosis coded in
their primary care records.
8 It is not known how many
of those without a code had the diagnosis recorded in
text or whether the GP was unaware of the diagnosis.
More research is needed to understand how clinicians
use diagnostic codes.
At present, the extent of cases missing in an
electronic record database is usually estimated by
comparison of rates obtained from within the database
with those from external sources.
9 Unless heroic
attempts are made to review thousands of case
records by hand it is difﬁcult to identify individual
diagnosed but uncoded cases at present. There are
resource implications for this labour-intensive work in
addition to important issues about anonymisation and
conﬁdentiality.
Bias due to variations in code-lists
The process of drawing up code-lists to identify all
patients with a given clinical condition is a critical step
in EHR studies. Multiple code-lists may be required
within one study for many different conditions such
as co-variates and confounders as well as disease
endpoints. But the process of preparing such code-lists
is far from straightforward, and lacks rigour. The
same clinical condition can be described using
many different codes. A patient with a given clinical
condition might receive one of several possible
diagnostic codes as well as, or instead of, one or
more codes describing symptoms or investigations.
This ﬂexibility in the coding structure facilitates the
clinical use of these codes, minimising the time spent
searching for codes by practitioners. However, this
multitude of codes for a given condition presents a
challenge when data need to be aggregated.
The selection of codes used to identify patients with
a condition will vary according to the particular
research question to be answered, reﬂecting in part the
degree of certainty of diagnosis required. Sometimes it
may be important to identify all possible cases but in
other studies the population may be restricted to cases
where the diagnosis is more certain. This variability in
code-lists may have major implicationsnot only forthe
results of any conﬁrmation studies but potentially for
results of all studies using EHR. Herrett highlights
three studies where different subsets of code-lists were
used in sensitivity analyses as a form of validation.
2
Differences in code-lists largely accounts for variation
of sevenfold in estimates of incidence of rheumatoid
arthritis.
10,11 Authors have begun to examine the effect
of code-list variation on study results
12,13 but this is an
area that needs further work. In our experience of
looking at the management of pelvic inﬂammatory
disease in primary care, codes classed as probable or
possible had implications for the estimates of the care
received.
14 Cases with possible codes were less likely
to receive recommended treatments, reﬂecting perhaps
diagnostic uncertainty, and were excluded from the ﬁnal
analyses (unpublished data, details available from author).
Future directions – natural language processing as
a tool for EHR research
Given the challenges inherent in attempting conﬁr-
mation and validation through free text, and the
potential for extensive bias due to code-list choice,
what else should we do to make EHR research more
robust? Fortunately, natural language processing
(NLP), a branch of computational linguistics, has the
potential to transform the availability of free text for
analysis.
15 In NLP, machine learning techniquescan be
used to train algorithms to extract textual information
that represents a code or concept, for example to ﬁnd
all the different ways that a diagnosis of rheumatoid
arthritis might be expressed in free text. In this way,
structured data can be derived from free text. Such
automatic processing of text using NLP algorithms
might facilitate searching of free text in, for example,
primary care records. This could assist in internal and
external validation by ﬁnding diagnoses in GP entered
text or in letters or discharge summaries from
secondary care. NLP might also help in the identiﬁ-
cation of false negatives where a diagnosis has been
recorded only in text. When that is possible, variations
in code-lists may become less importantbut, fornow, it
is important for researchers to explore the impact that
code choice is having on their results by including
sensitivity analyses.
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introduced by any automated processing of text.
For example, codes might be derived from text
which describes a suspected or possible rather than
certain diagnosis. NLP algorithms allow for inclusion
of negation and other measures of uncertainty. Such
uncertainty might be found within the text itself or
could be derived from the context of the data, such as a
GP entry compared to a more formal letter from
secondary care. GPs vary in the extent to which free
text is used and this variation will also affect the results
of NLP.
The potential errors introduced into research results
by using only coded data in electronic records have not
yet been quantiﬁed. The PREP project (http://www.
informatics.sussex.ac.uk/research/projects/PREP/1.htm)
has been funded by the Wellcome Trust to explore the
extent to which accessing the free text in GP records
affects the results of research. In particular, we are
asking whether information from free text changes
incidence estimates for rheumatoid arthritis or
estimates of the delay between ﬁrst presentation
and diagnosis of ovarian cancer. We are developing
methodologies to facilitate this access to text,
including techniques for anonymisation and NLP to
produce structured data in the form of additional
codes derived from text. As part of this development,
we will assess the accuracy of the data produced
by NLP. Complementary, ﬁeld studies exploring the
factors inﬂuencing data entry in GP surgeries will
use a human computer interaction approach to
increase our understanding of the balance between
coded and unstructured data.
We recommend that free text is considered as an
integral part of the electronic record and wherever
possible is included in research studies, so that its
contribution can continue to be assessed. Both internal
and external validation require free text information
and technological advances in free text processing
meanthatwemaybewithinsightofautomatedinternal
and external validation, including searching for false
negatives. The impact of code choice on study results
should, in the meantime, be routinely investigated by
the inclusion of sensitivity analyses.
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KEY POINTS
  Most studies using electronic health records rely
on coded data only.
  When assessing the validity of these codes, it is
important to separate the concepts of internal
validation (does the code reﬂect the practitioner’s
diagnosis?) and external validation (is this
diagnosis correct?).
  Existing validation studies are often unable to
look for false negatives, diagnosed cases which
have not been coded.
  Developments in natural language processing
may enable the more widespread use of the free
text contained in electronic records.
  In the meantime, the impact of code-list choice on
study results should be explored in sensitivity
analyses.
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